the perfect fit for your needs
TRANSCRIPT
GLO
BAL F
DA-IN
SPECTED A
SSETS
NORTH A
MERIC
A
PACK
AG
ING M
AN
UFACTU
RIN
G F
INIS
HED D
OSAGE C
HIR
FU
LLY I
NTEG
RATED S
OLU
TIO
NS M
AN
UFACTU
RIN
G A
NALY
T
GR
OW
TH
IN
VESTM
ENTS V
ALUE B
EYOND P
RIC
E INNOVATIO
N C
LI
PASSIO
N E
XPERIE
NCE F
DA-INSPECTED A
SSET
S G
ROW
TH V
AL
GROW
TH INVESTM
EN
TS V
ALUE B
EYOND P
RIC
E V
AL
NORTH A
MERIC
A U
NIT
ED K
INGDOM
INDIA
CHIR
AL T
ECHNOLOGY F
LEXIB
IL
PROJE
CT M
ANAGEM
CLIN
ICAL
CLIN
IC
AL T
RIA
LS
SE
RVIC
ES
CO
MM
ERCIA
L A
PIS
CL
INIC
AL T
RIA
LS S
ERVIC
ES F
ORM
ULATION
S
C
LIN
ICA
L T
RIA
L F
OR
MU
LATIO
NS
SER
VIC
ES H
IGH P
OTENCY S
U
BSTANC
ES C
LINICAL PHA
INVE
STM
EN
TS G
RO
WTH N
OR
TH A
MER
ICA U
NIT
ED K
INGDOM
INDIA
VALU
E BEYOND
EXP
ER
IEN
CE
EXC
ELLE
NC
E IN
NOVATIO
N P
ROCESS D
EVELOPM
ENT P
ACKAGIN
G A
NALY
TIC
AL SERVIC
ES
K
ING
DO
M I
ND
IA V
ALU
E B
EYO
ND
PR
ICE I
NVESTM
ENTS
FLEXIB
ILIT
Y P
RE C
LINIC
AL VALUE
K
ING
DO
M I
ND
IA V
ALU
E B
EYO
ND
PR
ICE G
LOBALLY INTEG
RATED S
OLU
TION
S F
ORMULAT
IO
NS
EXP
ER
IEN
CE
GLO
BA
L F
DA-I
NS
PECTED
ASSETS A
NALYTIC
AL S
ERVIC
ES P
ACKAGIN
G GRO
WTH
ANALYTIC
AL S
ERVIC
ES P
ROJECT M
AN
AG
EM
EN
T R
EGULATORY S
E
RVIC
E INN
OVATIO
N CLIN
ICA
L
GLO
BAL A
SSETS V
ALUE B
EYOND P
RIC
E I
NVESTM
ENTS GLOBAL ASSETS INVESTM
ENTS V
ALUE B
EYOND P
RIC
E GLOBAL
GLO
BA
L A
SS
ETS V
ALU
E B
EYON
D P
RIC
E I
NVESTM
EN
TS G
LOBAL A
SSETS CLIN
ICAL T
RIALS SERVIC
ES PHASE I
IN
NOVATIO
N P
RE C
LINICAL EXCELLE
N
CE
IN
NO
VATIO
N E
XC
ELLE
NC
E G
LO
BA
L A
SSETS V
ALU
E B
EYON
D P
RIC
E H
IGH P
OTENCY S
UBSTA
NCES G
LOBAL A
SSETS INVESTMENTS V
ALUE BEYO
ND P
RIC
E G
LOBAL F
DA-INSPECTED ASS
ETS
GLO
BA
L A
SS
ETS V
ALU
E B
EYOND P
RIC
E I
NVE
STM
ENTS G
LOBAL A
SSETS INVESTMENTS VALUE B
EYON
D P
RIC
E C
OM
MERCIA
L APIS PACKAG
IN
G
FDA-INSPECTED A
SSETS G
LOBAL A
SSETS V
ALUE B
EYOND PRIC
E INVESTM
ENTS G
LOBAL ASSETS IN
VESTMENTS VALUE B
E
YON
D
GLO
BA
L A
SSE
TS V
ALU
E B
EYOND P
R
ICE INVESTM
EN
TS GROWTH CLINICAL PHASE &
COM
MER
CIAL A
PIS
FORM
ULATIONS ASSET
S
FO
RM
ULATIO
NS C
LIN
ICA
L P
HAS
E A
PIS
CO
MM
ERCIA
L A
PIS
CLIN
ICAL T
RIA
LS S
ERVIC
ES C
OM
MERCIAL AP
IS
IND
IA U
NIT
ED
KIN
GD
OM N
OR
TH
AM
ER
ICA G
LOBAL F
DA-INSPE
CTED A
SSETS G
ROW
TH INVESTMENTS
CLIN
ICA
L P
HA
SE
AP
IS C
OM
MER
CIA
L A
PIS
CLIN
ICAL T
RIA
EXP
ER
IE
NC
E E
XC
ELLE
NC
E I
NN
OVATIO
N P
RO
CESS D
EVELOPM
EH
IGH
POTEN
CY S
UBSTANCES F
ULLY
IN
TEGRAT
ED S
OL
CO
MM
ER
CIA
L A
PIS
FORM
ULATIO
NS IN
VESTMENTS
CO
MM
ERCIA
L APIS NORTH AMERICA V A L U
ES
CO
MM
ERCIA
L APIS NORTH AMERICA VALUE
S
C
HIR
AL TECHNOLOGY GLOBAL S S S
S
C
HIR
AL TECHNOLOGY GLOBAL PA S
S
IO
GRO
WTH
CLINICAL TRIALS SER
G
ROW
TH
CLIN ICAL TR IALS S ERV I CE
S
CLIN
ICAL TRIALS SERVICES
CL INICAL TR IALS SERVICES
CLIN
IC
AL T
RIA
LS SERVICES VALUE BEYOND PRI CE GR
OW
TH
CLIN
IC
AL T
RIA
LS SERVICES VALUE BEYOND PRI CE GR
OW
TH
GLO
BAL A
SSETS N
ORTH
AMERICA UNITED KINGDOM INDIA SO
L
UTIO
NS
GLO
BAL A
SSETS N
ORTH
AMERICA UNITED KINGDOM INDIA SO
L
UTIO
NS
CH
IRAL T
ECHNOLO
GY FINISHED DOSAGE STERILE I N J E C TA
BL
ES
CH
IRAL T
ECHNOLO
GY FINISHED DOSAGE STERILE I N J E C TA
BL
ES
GR
OW
TH
HIG
H P
OTEN
CY SUBSTANCES FINISHED DOSAGE FLE X IB
ILIT
Y S
SS
S
GR
OW
TH
HIG
H P
OTEN
CY SU
BSTANCES FINISHED DOSAGE FLEXIBIL
IT
Y P
AS
S
CLIN
ICAL T
RIA
L
S S
ERVIC
ES CHIRAL TECHNOLOGY UNITED KINGDOM V
AL
UE
CLIN
ICAL T
RIA
L
S S
ERVIC
ES CHIRAL TECHNOLOGY UNITED KINGDOM VALU
E
CO
MM
ERCIA
L A
PIS
FULLY IN
TEGRATED SOLUTIONS GROWTH VALUE
GLO
BALLY IN
TEGR
ATED S
OLU
TIONS CLINICAL PHASE APIS API
GLO
BALLY IN
TEGRAT
ED S
OLU
TION
S CLINICAL
CLIN
ICAL T
RIA
LS S
ER
VIC
ES C
OM
MERCIAL APIS GLOBAL ASSETS
CH
IRAL T
ECH
NOLOGY C
OM
MERCIAL APIS UNITED K I NGDO M
CO
MM
ER
CIA
L A
PIS
FLE
XIB
ILIT
Y INVESTMENT GROWTH
CH
IRAL T
ECH
NOLOGY S
ERV
ICES C
OM
MERCIAL APIS
CH
IRAL T
ECH
NOLOGY H
IGH P
OTENCY S
UBSTANCES
CO
MM
ER
CIA
L A
PIS
GLO
BAL A
SSETS V
ALU
CLIN
ICA
L T
RIA
LS
SE
RVIC
ES
CH
IR
AL T
EC
HN
OLO
GY G
RO
WTH
CLIN
ICA
L T
RIA
LS
SE
RVIC
ES
CH
IR
AL T
EC
HN
OLO
GY G
RO
WTH
GR
OW
TH
H
IG
H P
OT
EN
CY
SU
BS
TA
NCES
GR
OW
TH
H
IG
H P
OT
EN
CY
SU
BS
TA
NGR
OW
TH
HIG
H P
OT
EN
CY
S
UB
STA
NC
ES
VA
LU
E
GR
OW
TH
HIG
H P
OTE
NC
Y S
UB
STA
NC
ES
VA
LU
E
GROW
TH
HIG
H P
OTEN
CY S
UB
STA
NC
ES
IN
NO
VATIO
N
GROW
TH H
IGH P
OTENCY S
UBSTAN
CES V
ALU
E B
EYO
ND
GLO
BAL A
SS
ETS
NO
RTH
AM
ER
IC
A U
NIT
ED
K
IN
GD
OM
IN
DIA
COM
MERCIA
L A
PI F
INIS
HED
DO
SAG
E G
RO
WTH
VA
LU
E
CH
IRAL T
ECHNOLOGY C
LIN
ICAL T
RIA
LS S
ER
VIC
ES V
ALU
CLINICAL PHASE & COM
MERCIA
L A
PIS
FIN
ISHED D
OSAGE
CLINIC
AL T
RIA
LS S
ERVIC
E
S N
ORTH A
MERIC
A I
ND
IA
VA
L
CLINICAL TRIALS SERVICES NORTH AM
E
CLINICAL TRIALS SERVICES NORTH AME
CLINICAL TRIALS SERVICES NORTH AME
CLINICAL TRIALS SERVICES NORTH AME
CLINICAL TRIALS SERVICES NORTH
CLINICAL TRIALS SERVICES NO
CLINICAL TRIALS SERVIC CLINICAL TRIALS SER CLINICAL TRIALS CLINICAL TRIA CLIN
ICAL TRIACLIN
IC
COMM
ERCIAL APIS
FULLY
INTE
GRATED S
OLU
TIO
NS V
ALU
COMMERCIAL APIS
COMMERCIAL APISSSS
EXPER
IEN
CE E
XCELLE
NCE INNOVA
TION P
ROCESS D
EVELOPMENT PROJECT MANAGEMENT IN
VE
STM
EN
T A
NA
LY
TIC
AL
S
ER
VIC
ES
A
NA
LY
TIC
AL
S
ER
VIC
ES
IN
NO
V
INN
OVATIO
N
PASSIO
N S
TABIL
ITY G
ROWTH
EXCELLENCE EXPERIENCE EXPERIEN
CE
PA
CK
AG
IN
G F
LE
XIB
IL
IT
Y F
IN
IS
HE
D D
OS
AG
E G
RO
WT
H
PRE C
LINIC
AL PH
ASE I COM
MERCIA
L APIS
CHIR
AL TECHNOLOGY FLEXIBILITY P
HASE
I CH
IR
AL
T
EC
HN
OL
OG
Y G
RO
WT
H F
OR
MU
LAT
IO
N
CLINIC
AL TRIA
LS SERVIC
ES CHIR
AL TECHNOLOGY UNITED KING
DOM
VA
LU
E B
EYO
ND
P
RIC
E IN
VE
ST
ME
NT
S
CHIRAL T
ECHNOLOGY FIN
ISHED D
OSAGE PRE CLINICAL STERILE IN
JEC
TA
BL
ES
C
OM
ME
RC
IA
L A
PIS
IN
VE
ST
ME
FORMULATIONS C
LINIC
AL PHASE APIS GROWTH CHIRAL T
ECH
NO
LO
GY
VA
LU
E B
EY
ON
D P
RIC
E
GROWTH HIG
H POTENCY SUBSTANCES COMMERCIAL APIS F
OR
MU
LATIO
NS
M
AN
UFA
CTU
RIN
G
GLOBAL ASSETS NORTH AMERICA GROWTH CHIR
AL T
ECH
NO
LO
GY PASSIO
N
INDIA INVESTMENTS GLOBAL ASSETS S
TABIL
ITY H
IGH P
OTEN
CY
INVESTMENTS GLOBAL ASSE
TS IN
VESTM
EN
TS V
ALU
E
VALUE BEYOND PRICE FO
RM
U
LATIO
NS
CLINICAL TRIALS S
ERVIC
E
COMMERCIAL APIS UNITED KINGDOM G
ROW
TH
FO
RM
ULATIO
NS G
RO
WTH VALUE
CLINIC
AL
PH
ASE A
PIS
CLIN
ICAL TRIALS
CLINICAL P
HASE A
PIS
CLIN
ICAL TRIALS
CLINICAL P
H
A
SE A
PIS CLINICAL TRIA
CLINICAL PHASE APIS CLINICAL TRIA
CLINICA
L P
HASE A
PIS
CLIN
ICA
L T
RIA
LS
SER
VIC
ES G
LO
BAL A
SSETS
CLINIC
AL P
HASE A
PIS
CLIN
ICA
L T
RIA
LS
SE
RVIC
ES E
XCELLEN
CE
CLIN
ICAL PH
ASE &
CO
MM
ER
CIA
L A
PIS
CLIN
ICA
L T
RIA
LS S
ERVIC
E
CLIN
ICAL P
HA
SE
A
PIS
C
LIN
IC
AL
T
RIA
LS
SE
RV
IC
ES
C
OM
ME
CLIN
ICAL PHASE A
PIS
C
LIN
IC
AL
T
RIA
LS
S
ER
VIC
ES
C
OM
ME
RC
IA
L A
PI
CLIN
ICAL P
HAS
E A
PIS
CLIN
ICAL TRIA
LS
S
ER
VIC
ES
IN
VE
ST
ME
NT
S G
RO
WT
H P
AS
SIO
N S
TA
BIL
IT
Y IN
NO
VAT
IO
CLIN
ICAL P
HA
SE C
LIN
ICAL T
RIA
LS S
ERVIC
ES IN
VESTM
EN
TS
G
RO
WT
H PA
SS
IO
N S
TA
BILITY I
NN
OVATIO
NS
VA
LU
E B
EY
ON
D P
RIC
E P
AS
SIO
N
APIS
CLIN
ICAL T
RIA
LS S
ERVIC
ES INVESTM
ENTS G
ROW
TH
PASSIO
N S
TABILITY INNOVATIO
NS
V
ALU
E B
EYON
D P
RIC
E P
ASSIO
N E
XCELLEN
CE E
XPER
IEN
CE G
RO
WTH
FD
A-IN
SP
EC
TE
D A
SS
ET
S P
RE
C
LIN
IC
A
CLINICA
L T
RIA
LS
S
ER
VIC
ES
C
OM
ME
RC
IA
L A
PIS
FO
RM
ULATIO
N
C
LINICA
L P
HA
SE
AP
IS
C
LIN
IC
AL
TR
IA
LS
SE
RVIC
ES F
ORM
ULATIO
FORMU
L
ATIO
NS C
OM
MERCIA
L A
PIS
CLIN
ICAL P
HAS
E A
PIS
CLINICAL P
HASE A
PIS
CLIN
ICAL T
RIA
LS
SERVICES
VA
LU
E BEYOND PRICE MANUFACTURIN
CL
INIC
AL P
HASE & COMMERCIAL A
P
C
LIN
ICAL P
HASE & COMMER
CIA
L A
CLIN
ICAL
PH
ASE &
COM
MER
CIA
L
A
CLIN
ICAL P
HASE &
COM
MER
CIA
L A
PIS
CLINIC
AL PHASE & COMMERCIAL APIS CLINIC
AL TRIALS SERVICES FOR
MU
LATIONS VALUE BEYOND PRICE GROW
T
H
CLIN
IC
AL &
COM
MER
CIA
L APIS
FO
RM
ULATIO
NS HIG
H POTENCY SUBSTAN
CE
S PRE C
LIN
ICAL IN
VESTM
ENTS G
ROW
TH V
ALUE B
EYON
D P
RIC
E H
IGH
PO
TEN
CY S
UB
STA
NC
ES
VA
LU
EB
EY
ON
D P
RIC
E IN
DIA
G
LO
BA
LLY
IN
TE
GR
ATE
D S
OLU
TIO
NS
VA
LU
E B
EYO
ND
PR
ICE G
ROW
TH V
AL
C
LIN
IC
AL
P
HA
SE
&
C
OM
ME
RC
IA
L A
PIS
P
HA
SE
III
HIGH POTENCY SUBSTANCES FORMULATIONS STA
BIL
ITY E
XPERIE
NCE
MANUFACTURING PACKAGING CHIR
AL T
EC
HNOLOGY IN
DIA
GLOBALLY INTEGRATED SOLU
TIO
NS E
XCELLEN
CE FD
A
GLO
BALLY IN
TEG
RATE
D S
OLU
TIO
NS P
RE
C
LIN
IC
AL
PHASE I CHIRAL TE
CHN
OLOGY C
LIN
ICAL P
HA
SE A
PIS
C
HIR
AL T
EC
HN
OLO
GY
CO
MM
ER
ICA
L &
CL
IN
IC
AL
PH
AS
E
FINIS
HED D
O
SAGE S
TERIL
E IN
JE
CTA
BLE
S P
AS
SIO
N
FO
RM
UL
AT
IO
NS
CLIN
ICAL P
HASE
FO
RM
ULATIO
NS
CLIN
ICAL P
HASE
FO
RM
ULATIO
NS C
LIN
ICAL
PH
ASE
CLIN
ICA
L T
RIA
LS
SE
RVIC
ES
CH
IR
AL
CL
IN
IC
AL
TR
IA
LS
SE
RVIC
ES
CH
IR
AL T
E
GR
OW
TH
HIG
H P
OT
EN
CY
S
UB
STA
GR
OW
TH
HIG
H P
OTE
NC
Y S
UB
STA
N
GR
OW
TH
HIG
H P
OTE
NC
Y S
UB
STA
N
GR
OW
TH
HIG
H P
OTE
NC
Y S
UB
STA
NC
GROW
TH
HIG
H P
OTE
NC
Y S
UB
STA
NC
E
GROW
TH
HIG
H P
OT
GROW
TH
HIG
H
GR
OW
TH
GR
O
PR
E C
LIN
ICA
L P
HA
SE I
FIN
ISH
ED D
OSAG
E C
HIR
AL TECH
NOLOGY G
LOBAL FDA-INSPECTED ASSETS NORTH AMERICA IN
DIA U
NITED K
ING
DOM
CL
IN
IC
ALTRIALS SERVICES FORMULATIONS VALUE
G
LO
BA
L FD
A- IN
SP
EC
TE
D A
SSETS
VALU
E B
EYO
ND
PR
ICE C
LINIC
AL TRIA
LS SERVIC
ES MANUFACTURIN
G PROCESS DEVELOPMENT REGULATORY SERVICES PROJECT MANAG
EMEN
T E
XP
ER
I
EN
CE EXCELLENCE INNOVATION EXCELLENCE
HIG
H P
OT
EN
CY
S
UB
STA
NC
ES
IN
VE
STM
ENTS F
DA-I
NSPECTE
D A
SSETS CLIN
ICAL T
RIALS S
ERVICES C
LINIC
AL & C
OM
MER
CIAL A
PIS F
ORM
ULATIO
NS P
RE C
LINIC
AL FLEXIBILITY VALUE BEYOND PRICE EXPERIE
NC
E IN
NOVATION FLEXIBILITY EXCELLENCE VALUE BEYO
ND
PRIC
E FORMULATIONS COMMERCIAL APIS
CLIN
ICAL P
HASE A
PIS
PRO
JECT M
ANAGEM
EN
T R
EGULATORY S
ERVIC
ES PACKA
GIN
G
MAN
AGEM
EN
T R
EG
ULATORY S
ER
VIC
ES
PA
CK
AG
ING
MAN
UFACTURIN
G P
ACK
AGING PASSIO
N
MA
NA
GE
ME
NT
RE
GU
LATO
RY S
ER
VIC
ES P
ACKAGIN
G MANUFACTU
RIN
G PHASE I FLEX
IBIL
IT
Y
CH
IRA
L T
EC
HN
OLO
GY P
RO
JE
CT M
AN
AG
EM
EN
T R
EG
ULATO
RY S
ER
VIC
ES F
LEXIB
ILIT
Y PR
E CLIN
ICAL M
AN
UFAC
TURIN
G V
ALU
E B
EYON
D P
RIC
E P
RE C
LINICA
L V
ALU
E
PA
SS
ION
CH
IR
AL T
EC
HN
OLO
GY
PR
OJE
CT
MA
NA
GE
MEN
T R
EGUL
ATORY S
ERVIC
ES FLE
XIBIL
ITY P
RE C
L
INIC
AL M
AN
UFACTUR
ING S
TERILE INJE
CTA
BL
ES
CH
IRA
L T
EC
HN
OLO
GY P
RO
JE
CT
MA
NA
GE
ME
NT R
EGUL
ATORY S
ERVIC
ES EXCE
LLEN
CE F
ORM
ULATIO
NS VALUE B
EYO
ND PRICE AS
SE
TS
PR
OJE
CT M
AN
AG
EM
EN
T R
EG
ULATO
RY S
ERVIC
ES F
LEXIBIL
ITY C
HIR
AL TECH
NOLO
GY P
RE C
LIN
ICAL F
INISHED
DO
SA
GE
NO
RTH
AM
ER
ICA F
OR
MU
LATIO
NS
CH
IR
AL T
EC
HN
OLO
GY P
AC
KAG
ING
CLIN
ICAL T
RIA
LS S
ER
VIC
E F
LEXIB
ILIT
Y
GLO
BA
LFD
A-IN
SPECTED
ASSETS IN
DIA
FO
RM
ULATIO
NS
CLIN
IC
ALP
HASE A
PIS
CH
IR
AL T
EC
HN
OLO
GY P
RE
CLIN
ICAL
EXC
ELLE
NC
E V
ALU
E B
EYO
ND
PR
ICE
AN
ALY
TIC
AL S
ER
VIC
ES
PA
SSIO
N
F
OR
MU
LATIO
NS
REG
ULATORY
GLOBAL FDA-INSPECTED ASSETS
VALUE BEYOND PRIC
E
FULLY INTEGRATED SOLUTIO
NS
The Perfect Fit
For Your Needs
OUR GLOBALLY INTEGRATED ASSETS OFFER THE OPTIMAL
SERVICE MIX TO SUIT OUR CUSTOMERS’ NEEDS
E^gVbVa�=ZVai]XVgZ�^h�V�\adWVa�XdbeVcn�l^i]�V�\gdl^c\�
cZildg`�d[�VhhZih�adXViZY�VXgdhh�Cdgi]�6bZg^XV!�:jgdeZ�VcY�
6h^V#�L^i]�djg�hiViZ"d["i]Z"Vgi�[VX^a^i^Zh�lZ�VgZ�dcZ�d[�i]Z�
[Zl�8BDh�i]Vi�XVc�egdk^YZ�ZcY"id"ZcY�hjeedgi�id�hZgk^XZ�
ndjg�Ygj\�YZkZadebZci�cZZYh#
Djg�XVeVW^a^i^Zh�^cXajYZ�6E>�EgdXZhh�9ZkZadebZci!�Cdc�<BE$
<BE�6E>!�=^\]�EdiZcXn�6E>h!�8dbbZgX^Va�6E>!�6cVani^XVa�
HZgk^XZh!�EgZ"[dgbjaVi^dch!�;dgbjaVi^dch�9ZkZadebZci!�8B8�
HZgk^XZh!�8a^c^XVa�Ig^Vah�HZgk^XZh!�8dbbZgX^Va�;dgbjaVi^dch�
VcY�8dbbZgX^Va�EVX`V\^c\#�L^i]�djg�^ciZ\gViZY�hZgk^XZ�
d[[Zg^c\h!�igjan�Xjhidb^oZY�hdaji^dch�WZXdbZ�V�gZVa^in#
�K^h^i�jh�Vi�lll#e^gVbVae]VgbVhdaji^dch#Xdb�
dg�XVaa� &�,('�*).�.)*&�m�'%*
;dg�\ZcZgVa�Zcfj^g^Zh!�ZbV^a/�
:cfj^g^Zhe]VgbVhdaji^dch@e^gVbVa#Xdb